Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/05/2026 | Q4 | $5.8B | -- | -- | $2.78 | -- |
| 10/30/2025 | Q3 | $5.5B | $5.7B | $2.46 | $2.57 | -$0.11 |
| 07/24/2025 | Q2 | $5.3B | $5.4B | $2.44 | $2.50 | -$0.06 |
| 04/24/2025 | Q1 | $5.2B | $5.1B | $2.04 | $2.32 | -$0.28 |
| 01/30/2025 | Q4 | $5.5B | $5.5B | $2.38 | $3.42 | -$1.04 |
| 10/24/2024 | Q3 | $5.3B | $5.3B | $2.10 | $3.26 | -$1.17 |
| 07/25/2024 | Q2 | $5.3B | $5.3B | $1.92 | $3.18 | -$1.26 |
| 04/25/2024 | Q1 | $5.1B | $5.2B | $1.48 | $2.91 | -$1.43 |
| 01/25/2024 | Q4 | $5.3B | $5.3B | $0.83 | $3.31 | -$2.48 |
| 10/26/2023 | Q3 | $4.9B | $4.9B | $2.01 | $3.03 | -$1.02 |
| 07/26/2023 | Q2 | -- | $4.7B | $1.84 | -- | -- |
| 04/27/2023 | Q1 | -- | $4.5B | $1.76 | -- | -- |
| 01/26/2023 | Q4 | -- | $4.6B | $2.17 | -- | -- |
| 10/28/2022 | Q3 | -- | $4.2B | -$1.57 | -- | -- |
| 07/28/2022 | Q2 | -- | $4.1B | $2.43 | -- | -- |
| 04/29/2022 | Q1 | -- | $4.1B | $2.43 | -- | -- |
| 01/31/2022 | Q4 | -- | $4.4B | $2.46 | -- | -- |
| 10/29/2021 | Q3 | -- | $4.2B | $2.39 | -- | -- |
| 08/03/2021 | Q2 | -- | $4.7B | $2.01 | -- | -- |
| 04/30/2021 | Q1 | -- | $4.6B | $2.24 | -- | -- |
| 01/29/2021 | Q4 | -- | $4.7B | $0.91 | -- | -- |
| 10/30/2020 | Q3 | -- | $4.5B | $1.98 | -- | -- |
| 07/31/2020 | Q2 | -- | $4.4B | $1.30 | -- | -- |
| 05/05/2020 | Q1 | -- | $4.6B | $0.99 | -- | -- |
| 02/04/2020 | Q4 | -- | $4.8B | $1.80 | -- | -- |
| 10/30/2019 | Q3 | -- | $4.4B | $1.90 | -- | -- |
| 07/31/2019 | Q2 | -- | $1.9B | $2.21 | -- | -- |
| 05/01/2019 | Q1 | -- | $7.4B | $4.61 | -- | -- |
| 01/29/2019 | Q4 | -- | $1.7B | $1.87 | -- | -- |
| 10/14/2018 | Q3 | -- | $1.5B | $1.77 | -- | -- |
| 07/31/2018 | Q2 | -- | $1.7B | $1.78 | -- | -- |
| 05/02/2018 | Q1 | -- | $1.6B | $1.65 | -- | -- |
| 01/30/2018 | Q4 | -- | $1.5B | $1.08 | -- | -- |
| 10/31/2017 | Q3 | -- | $1.4B | $1.33 | -- | -- |
| 08/01/2017 | Q2 | -- | $1.5B | $1.14 | -- | -- |
| 05/03/2017 | Q1 | -- | $1.5B | $0.63 | -- | -- |
| 02/02/2017 | Q4 | -- | $1.4B | $1.45 | -- | -- |
| 11/01/2016 | Q3 | -- | $1.4B | $1.29 | -- | -- |
| 08/02/2016 | Q2 | -- | $1.5B | $1.28 | -- | -- |
| 05/03/2016 | Q1 | -- | $1.6B | $1.33 | -- | -- |
| 02/02/2016 | Q4 | -- | $1.7B | -$1.06 | -- | -- |
L3Harris Technologies, Inc. reported $5.7B worth of top line sales in its most recent quarter.
L3Harris Technologies, Inc. announced earnings per share of $2.46 which represents a miss of analyst forecast a $2.57 per share.
L3Harris Technologies, Inc. reported $1.3B that represents $7.00 per share over the last quarter.
L3Harris Technologies, Inc.'s earnings are forecast to grow from $7.88 per share to $13.07 per share next year representing an increase of 35.35%.
L3Harris Technologies, Inc.'s next earnings date is February 5, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.